Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Roivant Sciences Ltd.

NASDAQ: ROIV · Life Sciences · 11 alerts · CIK 1635088

Share price
$38.61Close, Nov 16
Market cap
$28B
Shares outstanding
724.56MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Roivant Sciences Ltd. filings on SEC EDGAR ↗

7:01 PM ET Form 4
Insider Selling

Roivant Sciences CFO Richard Pulik Sells $12.5M of Stock

Richard Pulik, CFO, sold 300,000 shares of Roivant Sciences Ltd. at $41.20 to $42.03 a share (average $41.58) in 4 transactions, worth $12.5M in total between Nov 10, 2026 and Nov 11, 2026. Shares held after the trade: 222,046 (-17.7%).

Value
$12.5M
Shares
300,000
Average price
$41.58
Role
CFO
Holding change
-17.7%
Trade date
Nov 10, 2026 to Nov 11, 2026
7:00 PM ET Form 4
Insider Selling

Roivant Sciences President & Immunovant CEO Eric Venker Sells $7.62M of Stock

Eric Venker, President & Immunovant CEO, sold 187,943 shares of Roivant Sciences Ltd. at $40.44 to $41.00 a share (average $40.53) in 2 transactions, worth $7.62M in total on Nov 10, 2026. Shares held after the trade: 811,211 (-3.5%).

Value
$7.62M
Shares
187,943
Average price
$40.53
Role
President & Immunovant CEO
Holding change
-3.5%
Trade date
Nov 10, 2026
6:11 PM ET Form 4
Insider Selling

Roivant Sciences President & Immunovant CEO Eric Venker Sells $7.26M of Stock

Eric Venker, President & Immunovant CEO, sold 200,000 shares of Roivant Sciences Ltd. at $36.31 a share, worth $7.26M in total on Nov 3, 2026. Shares held after the trade: 999,154 (-16.7%).

Value
$7.26M
Shares
200,000
Price
$36.31
Role
President & Immunovant CEO
Holding change
-16.7%
Trade date
Nov 3, 2026
6:29 PM ET Form 4
Insider Selling

Roivant Sciences President & Immunovant CEO Eric Venker Sells $7.32M of Stock

Eric Venker, President & Immunovant CEO, sold 200,000 shares of Roivant Sciences Ltd. at $36.59 a share, worth $7.32M in total on Oct 28, 2026. Shares held after the trade: 1,199,154 (-14.3%).

Value
$7.32M
Shares
200,000
Price
$36.59
Role
President & Immunovant CEO
Holding change
-14.3%
Trade date
Oct 28, 2026
6:44 PM ET Form 4
Insider Selling

Roivant Sciences President & Immunovant CEO Eric Venker Sells $7.02M of Stock

Eric Venker, President & Immunovant CEO, sold 200,000 shares of Roivant Sciences Ltd. at $35.09 to $35.42 a share (average $35.11) in 2 transactions, worth $7.02M in total on Oct 20, 2026. Shares held after the trade: 1,399,154 (-1.0%).

Value
$7.02M
Shares
200,000
Average price
$35.11
Role
President & Immunovant CEO
Holding change
-1.0%
Trade date
Oct 20, 2026
6:06 PM ET Form 4
Insider Selling

Roivant Sciences Insider Melissa B. Epperly Sells $641K of Stock

Melissa B. Epperly sold 17,750 shares of Roivant Sciences Ltd. at $36.08 to $36.57 a share (average $36.10) in 2 transactions, worth $641K in total on Oct 1, 2026. Shares held after the trade: 14,954 (-5.7%).

Value
$641K
Shares
17,750
Average price
$36.10
Holding change
-5.7%
Trade date
Oct 1, 2026
5:38 PM ET Form 4
Insider Selling

Roivant Sciences President & Immunovant CEO Eric Venker Sells $7.32M of Stock

Eric Venker, President & Immunovant CEO, sold 200,000 shares of Roivant Sciences Ltd. at $36.62 a share, worth $7.32M in total on Sep 30, 2026. Shares held after the trade: 1,599,154 (-11.1%).

Value
$7.32M
Shares
200,000
Price
$36.62
Role
President & Immunovant CEO
Holding change
-11.1%
Trade date
Sep 30, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.